Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001140361-12-045375
Filing Date
2012-11-02
Accepted
2012-11-02 14:18:32
Documents
1
Effectiveness Date
2012-11-02
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9094
  Complete submission text file 0001140361-12-045375.txt   10415
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: D | Act: 33 | File No.: 021-186444 | Film No.: 121176275
SIC: 2834 Pharmaceutical Preparations